NCT01283386 2019-03-14A Study to Compare Mabthera (Rituximab), Fludarabine and Cyclophosphamide to Mabthera and Chlorambucil in Participants With Chronic Lymphocytic Leukemia and Unfavorable Somatic StatusHoffmann-La RochePhase 4 Terminated26 enrolled 13 charts